Biogen
(NASDAQ) BIIB
Biogen Financials at a Glance
Market Cap
$31.91BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$9.86B
Net Income (TTM)
$1.37B
EPS (TTM)
$9.32
P/E Ratio
23.19
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$208.47
Volume
1,218,436.145
Open
$215.95
Price
$208.47
Volume
1,218,436.145
Open
$215.95
Previous Close
$208.46
Daily Range
$208.27 - $215.95
52-Week Range
$121.05 - $219.72
Estimated Earnings Date
Jul 29, 2026
Dividend
$0.00
Beta (Volatility)
0.71 (Low)
Price
$208.47
Volume
1,218,436.145
Open
$215.95
Previous Close
$208.46
Daily Range
$208.27 - $215.95
52-Week Range
$121.05 - $219.72
Estimated Earnings Date
Jul 29, 2026
BIIB News
BIIB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biogen
Industry
Biotechnology
Sector
Health CareEmployees
7,500
CEO
Christopher A. Viehbacher, CPA
Website
www.biogen.comHeadquarters
Cambridge, MA 02142, US
BIIB Financials
Key Financial Metrics (TTM)
Gross Margin
69.77%
Operating Margin
15.65%
Net Income Margin
13.92%
Return on Equity
7.55%
Return on Capital
7.45%
Return on Assets
4.65%
Earnings Yield
4.31%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$31.91BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
147.64M
Volume
1.22M
Avg. Volume
1.20M
Financials (TTM)
Gross Profit
$6.88B
Operating Income
$1.54B
EBITDA
$2.70B
Operating Cash Flow
$2.59B
Capital Expenditure
$32.30M
Free Cash Flow
$2.62B
Cash & ST Invst.
$4.28B
Total Debt
$6.56B
Biogen Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.48B
+1.9%
Gross Profit
$1.82B
-2.0%
Gross Margin
73.32%
N/A
Market Cap
$31.91BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$4.20M
N/A
Employees
7,605
N/A
Net Income
$319.50M
+32.8%
EBITDA
$553.60M
-36.0%
Quarterly Fundamentals
Total Cash
$4.28B
+64.8%
Total Debt
$6.56B
-0.9%
Accounts Receivable
$1.79B
-10.3%
Inventory
$1.95B
-14.3%
Long Term Debt
$6.56B
+34.7%
Short Term Debt
$0.00
-100.0%
Return on Assets
4.65%
N/A
Return on Invested Capital
5.82%
N/A
Free Cash Flow
$696.70M
+228.3%
Operating Cash Flow
$645.50M
+148.9%